In recent years, for the need to control product prices and participate in market competition, pharmaceutical manufacturing companies have strengthened the power of self-selling. However, in the process, some problems such as the excessive number of SMEs and excess production capacity have emerged. This shows that the concentration of the pharmaceutical industry has yet to be improved.
China is a big producer of chemical raw material drugs, and its output ranks second in the world. However, the level of research and development of pharmaceutical preparations is low. Most of the preparations are of low quality and have poor stability and are difficult to enter the international market. At present, China's average raw material medicine can only be made into three kinds of preparation products, while a foreign raw material medicine can do dozens or even dozens of preparation products. Most of the domestic medical device products are conventional low-end products with low added value. The product repair rate and shutdown rate are high, and the product performance is unstable. The high-grade, precise, and sharp medical devices and new practical medical equipment required for clinical use are mostly dependent on imports. .
At present, the investment in scientific research and development of pharmaceutical machinery companies in China is insufficient. The investment in research and development of multinational pharmaceutical companies generally accounts for a large proportion of total sales, but it is obviously insufficient in China. The insufficiency of scientific research investment has made China's pharmaceutical products with independent intellectual property rights less, product updates are slow, and duplication is serious. The 97 varieties of chemical raw material drugs are "imitation" products; secondly, the level of China's medical equipment also needs to be improved. The equipment of most pharmaceutical companies in China is still based on mechanization. There is still a long way to go before the developed countries have entered the stage of production of automated equipment based on computer control. In addition, the mechanism for the rapid industrialization of scientific and technological achievements has not yet been fully formed. The conversion rate of China's pharmaceutical scientific and technological achievements is only about 8%, and only 2%-3% of the industrialized production actually takes shape.
In the past, people in the industry were concerned about the issue of overcapacity. They were only considering the market capacity and the low level of product repetition. Now, the problem of overcapacity has directly led to the heavy debt burden of enterprises.
Therefore, the relevant departments of the state must strengthen the emphasis on the pharmaceutical field, issue related policies for pharmaceuticals, promote the adjustment of the organizational structure of the company, and improve the overall technical strength of the pharmaceutical industry.
China is a big producer of chemical raw material drugs, and its output ranks second in the world. However, the level of research and development of pharmaceutical preparations is low. Most of the preparations are of low quality and have poor stability and are difficult to enter the international market. At present, China's average raw material medicine can only be made into three kinds of preparation products, while a foreign raw material medicine can do dozens or even dozens of preparation products. Most of the domestic medical device products are conventional low-end products with low added value. The product repair rate and shutdown rate are high, and the product performance is unstable. The high-grade, precise, and sharp medical devices and new practical medical equipment required for clinical use are mostly dependent on imports. .
At present, the investment in scientific research and development of pharmaceutical machinery companies in China is insufficient. The investment in research and development of multinational pharmaceutical companies generally accounts for a large proportion of total sales, but it is obviously insufficient in China. The insufficiency of scientific research investment has made China's pharmaceutical products with independent intellectual property rights less, product updates are slow, and duplication is serious. The 97 varieties of chemical raw material drugs are "imitation" products; secondly, the level of China's medical equipment also needs to be improved. The equipment of most pharmaceutical companies in China is still based on mechanization. There is still a long way to go before the developed countries have entered the stage of production of automated equipment based on computer control. In addition, the mechanism for the rapid industrialization of scientific and technological achievements has not yet been fully formed. The conversion rate of China's pharmaceutical scientific and technological achievements is only about 8%, and only 2%-3% of the industrialized production actually takes shape.
In the past, people in the industry were concerned about the issue of overcapacity. They were only considering the market capacity and the low level of product repetition. Now, the problem of overcapacity has directly led to the heavy debt burden of enterprises.
Therefore, the relevant departments of the state must strengthen the emphasis on the pharmaceutical field, issue related policies for pharmaceuticals, promote the adjustment of the organizational structure of the company, and improve the overall technical strength of the pharmaceutical industry.
Vibrating Screen, 800 mm diameter Sieve Machine is a standard and popular size sieve machine. it is not big and not small, the vibratory sieve machine is easy to operation.
It is widely used in food, medicine, chemical industry, abrasive, pigment, mining, metallurgy, geology, ceramics, national defense and other industries, scientific research institutions, production control and so on. Used for testing of solids, powders, pastes, etc. Screening, classification, particle size analysis, impurity content analysis, etc.
800mm Sieve, Diameter 800mm Sifter, 800mm Vibrating Screen, 800mm Sieve Machine, stainless steel vibrating screen
Xinxiang Xin Ming De Machinery Co., Ltd. , https://www.xmdsieve.com